April 30, 2018

EMED’s CEO Duane Boise Provides Mission Critical Success

FORT LAUDERDALE, FL / ACCESSWIRE / April 13, 2018 / A cancer diagnosis is never good news to receive, and it’s even more unfortunate when a […]
March 14, 2018

MMJ BioScience Partner Receives Health Canada License to Manufacture Cannabis Medicine for FDA Study

RESTON, VA / ACCESSWIRE / March 10, 2018 / MMJ International Holdings, the premier medical cannabis research company, advancing the science of medical marijuana legally through […]
February 7, 2018

MMJ International Holdings Focuses on FDA Approved Multiple Sclerosis Study with Medical Cannabis

RESTON, VA / ACCESSWIRE / February 5, 2018 / MMJ International Holdings, the premier medical cannabis research company that is advancing the science of medical marijuana […]
January 13, 2018

MMJ BioScience Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical Cannabidiol (CBD) derived medicine.

MMJ BioScience’s FDA application to initiate clinical trials assessing the company’s cannabinoid pharmaceutical compounds for treating and/or preventing symptoms associated with multiple sclerosis (MS) has been […]
January 9, 2018

MMJ International Holdings Legally Pursues FDA For Cannabis New Drug Approval

MMJ International Holdings Legally Pursues FDA For Cannabis New Drug Approval BUFFALO, NY / ACCESSWIRE / January 8, 2018 / MMJ International Holdings, the premier medical […]
January 8, 2018

MMJ International Holdings Files US Patent Prior to FDA Study for Cannabinoid Treatment Medicine

MMJ International Holdings Files US Patent Prior to FDA Study for Cannabinoid Treatment Medicine RESTON, VA / ACCESSWIRE / January 2, 2018 / MMJ International Holdings, […]
December 16, 2017

MMJ BioScience Announces Partnership with Pharmaceutical Manufacturing Company To Supply Cannabis Medicine For Multiple Sclerosis Study

MMJ BioScience Announces Partnership with Pharmaceutical Manufacturing Company To Supply Cannabis Medicine For Multiple Sclerosis Study MMJ Bioscience now offers excellence in cannabinoid medicine manufacturing thats […]
December 12, 2017

MMJ BioScience Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical Cannabidiol (CBD) derived medicine.

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment MMJ International Holding’s, the premier medical cannabis research company that is advancing the science […]
November 27, 2017

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment MMJ International Holdings, the premier medical cannabis research company that is advancing the science […]